The COVID-19 vaccine distribution process continues in Vermont and northern New York.
As Covid-19 transmission ramps up in the United States, recent changes to federal vaccine guidance have left many Americans confused about the latest policies and concerned about access to shots this ...
As much as we want to put it behind us, COVID-19 isn’t going away. Cases are currently rising across the country in a summer surge. The U.S. Centers for Disease Control and Prevention (CDC) reports ...
HealthDay on MSN
FDA approves Xocova for COVID-19 postexposure prophylaxis
The U.S. Food and Drug Administration has approved Xocova (ensitrelvir), an oral antiviral, for postexposure prophylaxis (PEP ...
COVID-19 variant BA.3.2 or "cicada" is not widely circulating in the U.S. yet, but based on trends in Europe, it may become more prominent. Most evidence comes from laboratory data, but there are no ...
The FDA has approved the first and only pill to prevent COVID-19 after exposure to the virus. Here's how it works. (Photo: ...
The US Food and Drug Administration (FDA) has green-lit updated COVID-19 vaccines for the 2025–26 season for select groups, but confusion is already mounting over how physicians and insurers will ...
The US Food and Drug Administration approved updated Covid-19 vaccines Wednesday, but for a limited group: adults 65 and older, and younger people who are at higher risk from Covid-19. “FDA has now ...
No. COVID-19 vaccines have not been linked to as many as 3.9 million deaths. Wisconsin U.S. Sen. Ron Johnson said on May 9, ...
School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research led by Oxford ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results